Lysosomal storage disorders: Morphologic appraisal in Indian population

被引:2
|
作者
Pradhan, Dinesh [1 ]
Varma, Neelam [1 ]
Gami, Ashmita [2 ]
Hura, Kanwaljeet Singh [3 ]
Mohanty, Sambit K. [4 ]
机构
[1] Post Grad Inst Med Educ & Res, Dept Pathol, Chandigarh, India
[2] Grant Med Coll, Dept Pediat, Bombay, Maharashtra, India
[3] Pt JNM Med Coll, Dept Pediat, Raipur, Chhattisgarh, India
[4] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA
关键词
Anemia; gaucher's; lysosomal storage disorders; non-Gaucher's; thrombocytopenia; GAUCHER-DISEASE;
D O I
10.4103/0973-1482.157313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lysosomal storage disorders (LSDs) comprise a group of at least 50 distinct genetic diseases, each one resulting from the deficiency of a particular lysosomal enzyme involved in metabolism. We attempt to study and further subclassify pediatric LSDs into Gaucher's and non-Gaucher's category based on the morphologic variables seen in the bone marrow aspiration smears and trephine biopsy sections. Materials and Methods: Pediatric (<12 years age) cases of LSDs diagnosed by bone marrow aspiration and trephine biopsy specimens, in the last 12 years period, were retrieved. The archival material and the relevant clinical as well as hematologic parameters were reviewed. Results: From January 1997 to December 2008, 55 cases were diagnosed as LSDs. Based on bone marrow morphology, 56% (n = 31) cases were diagnosed as non-Gaucher's and the remaining 44% (n = 24) cases as Gaucher's disease, the ratio being 1.29:1. Anemia and thrombocytopenia were more commonly observed in Gaucher's disease (91.67 and 62.5%) as compared to non-Gaucher's group (74.19 and 19.35%). Neurologic symptoms and signs were more frequently present in non-Gaucher's cases (45.16%) as compared to Gaucher's group (29.17%). Conclusion: LSDs can be classified into Gaucher's and non-Gaucher's subtypes based on the characteristic cytomorphology of the storage cells in Giemsa-stained bone marrow aspiration smears and on hematoxylin and eosin-stained trephine biopsy sections. This approach would be fairly adequate for therapeutic and prognostic purposes in resource-constrained settings, where enzyme studies and mutational analysis may not be easily available.
引用
收藏
页码:442 / 445
页数:4
相关论文
共 50 条
  • [21] Prevalence of lysosomal storage disorders
    Meikle, PJ
    Hopwood, JJ
    Clague, AE
    Carey, WF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03): : 249 - 254
  • [22] Sphingolipid lysosomal storage disorders
    Frances M. Platt
    Nature, 2014, 510 : 68 - 75
  • [23] Immunochemistry of lysosomal storage disorders
    Parkinson-Lawrence, Emma
    Fuller, Maria
    Hopwood, John J.
    Meikle, Peter J.
    Brooks, Doug A.
    CLINICAL CHEMISTRY, 2006, 52 (09) : 1660 - 1668
  • [24] Lysosomal Storage Disorders in the Newborn
    Staretz-Chacham, Orna
    Lang, Tess C.
    LaMarca, Mary E.
    Krasnewich, Donna
    Sidransky, Ellen
    PEDIATRICS, 2009, 123 (04) : 1191 - 1207
  • [25] PSEUDODEFICIENCIES IN LYSOSOMAL STORAGE DISORDERS
    ZLOTOGORA, J
    BACH, G
    LANCET, 1985, 2 (8467): : 1296 - 1296
  • [26] Treatments for lysosomal storage disorders
    Lachmann, Robin
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1465 - 1468
  • [27] Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
    Platt, Frances M.
    Boland, Barry
    van der Spoel, Aarnoud C.
    JOURNAL OF CELL BIOLOGY, 2012, 199 (05): : 723 - 734
  • [28] New treatments for lysosomal storage disorders
    Wilmott, RW
    JOURNAL OF PEDIATRICS, 2004, 144 (05): : 2A - 2A
  • [29] Gene therapy for the lysosomal storage disorders
    Cabrera-Salazar, MA
    Novelli, E
    Barranger, JA
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2002, 4 (04) : 349 - 358
  • [30] Lysosomal storage disorders: Present and future
    Phadke, Shubha R.
    INDIAN PEDIATRICS, 2015, 52 (12) : 1025 - 1026